What are the effects of Monosialotetrahexosylganglioside?
1.
Monosialotetrahexosylganglioside is clinically used primarily for the treatment of vascular or traumatic central nervous system injuries as well as Parkinson's disease. It is important to note that a few patients may experience skin rash reactions after using this medication. If an allergic reaction occurs, the medication should be discontinued. Additionally, this medication is contraindicated for some patients, such as those with genetic disorders of glycolipid metabolism. In summary, monosialotetrahexosylganglioside is a treatment medication for neurological diseases, which can be used for central nervous system injuries and Parkinson's disease.
2.
Vascular or traumatic central nervous system injuries; Parkinson's disease. It is used for the treatment of vascular or traumatic central nervous system injuries, spinal cord injuries, cerebral atrophy, cerebral infarction, cerebral hemorrhage, brain injury, cerebral palsy in children, hypoxic-ischemic encephalopathy in newborns, peripheral neuritis in children, Parkinson's disease, and diabetic cranial neuropathy.